FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/12/078608 [Registered on: 26/12/2024] Trial Registered Prospectively
Last Modified On: 25/12/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Surgical/Anesthesia 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Comparison of ultrasound guided two nerve blocks in hip region for hip surgeries- Prospective randomised control trail 
Scientific Title of Study   Comparison of ultrasound guided anterior quadratus lumborum block versus combined pericapsular nerve group block with lateral femoral cutaneous nerve block in hip surgeries-Prospective randomised control trail 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  DR Mohammed Arfak H 
Designation  PG student 
Affiliation  Sri Ramachandra Institute of higher education and research 
Address  natesan nagar alapakkam chennai 116

Thiruvallur
TAMIL NADU
600116
India 
Phone  9952763355  
Fax    
Email  mohammedarfak96@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DR Rajesh Kumar Kodali V 
Designation  Professor 
Affiliation  Sri Ramachandra Institute of higher education and research 
Address  Department of Anesthesia, Flat No 30,F block, SRMC Staff quarters, Porur, Chennai 60016

Thiruvallur
TAMIL NADU
600116
India 
Phone  9962398266  
Fax    
Email  Vrajesh.kodali@gmail.com  
 
Details of Contact Person
Public Query
 
Name  DR Rajesh Kumar Kodali V 
Designation  Professor 
Affiliation  Sri Ramachandra Institute of higher education and research 
Address  Department of Anesthesia, Flat No 30,F block, SRMC Staff quarters, Porur, Chennai 60016

Thiruvallur
TAMIL NADU
600116
India 
Phone  9962398266  
Fax    
Email  Vrajesh.kodali@gmail.com  
 
Source of Monetary or Material Support  
Sri Ramachandra Institute of Higher Education and Research,Porur,Chennai 600 116,Tamil nadu,India 
 
Primary Sponsor  
Name  Sri Ramachandra Institute of Higher Education and Research 
Address  No 1,Sri Ramachandra Nagar, Chennai 60016, Tamil Nadu, India 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
DR Mohammed Arfak H  Sri Ramachandra Institute of Higher Education and Research Institute  No1,Ramachandra Nagar,Sri Ramachandra nagar,Chennai
Chennai
TAMIL NADU 
09952763355

mohammedarfak96@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
The Institutional Ethics Committee (for Medical PG Students),SRIHER(DU)  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: M00-M99||Diseases of the musculoskeletal system and connective tissue,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Ultrasound guided anterior quadratus lumborum block  Patient will receive ultrasound guided anterior quadratus lumborum block with 25ml of 0.25% ropivacaine and 0.1mg/kg of dexamethasone before spinal anesthesia 
Comparator Agent  Ultrasound guided pericapsular nerve group block with lateral femoral cutaneous nerve block  Patient will receive ultrasound guided pericapsular nerve group block with lateral femoral cutaneous nerve block with 22ml pericapsular nerve group block combined with 3ml of lateral femoral cutaneous nerve block with 0.25% ropivacaine and 0.1mg/kg of dexamethasone before spinal anesthesia 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  American Society of Anesthesiologist (ASA) I and II 
 
ExclusionCriteria 
Details  Patient refusal for participation
Known coagulation disorder
Allergies to study drugs
Chronic pain
Morbidly obese
Emergency surgeries 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant, Investigator and Outcome Assessor Blinded 
Primary Outcome  
Outcome  TimePoints 
Amount of rescue analgesia consumption  0 hour,2 hours,4 hours,8 hours,12 hours,24 hours 
 
Secondary Outcome  
Outcome  TimePoints 
Post operative pain intensity(NRS scale)
Duration of analgesia
Time for initial rescue analgesia
Hemodynamic data such as heart rate, systolic BP, diastolic BP, mean arterial pressure, saturation of oxygen
 
30 minutes,1 hour,2 hours,4 hours,8 hours,12 hours,24 hours 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   10/01/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   Patient who fit in to inclusion criteria will be enrolled into the study after getting written informed consent from the patient. All patient’s assessment will be done on the previous day and nil per oral orders will be given as per department protocol.Baseline blood pressure and heart rate will be recorded before shifting to operating room.After shifting to operating room electrocardiography, non invasive blood pressure and oxygen saturation will be connected. A total of 60 patients of ASA I and II(aged 20-60 years) undergoing hip surgeries will be randomly allocated into two groups of 30 each.Group 1 will receive ultrasound guided anterior quadratus lumborum block with 25 ml of 0.25% ropivacaine with 0.1mg/kg of dexamethasone and Group 2 will receive combined pericapsular nerve group block (22ml) with lateral femoral cutaneous nerve block (3ml) with 0.25% ropivacaine with 0.1 mg/kg of dexamethasone before spinal anesthesia.Intraoperatively  heart rate, non invasive blood pressure and oxygen saturation will be monitored every 3 minutes for first 15 minutes and at 5 minutes for next 15 minutes. 
Close